These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 36304086)
21. Evolving role of artificial intelligence in gastrointestinal endoscopy. Parasher G; Wong M; Rawat M World J Gastroenterol; 2020 Dec; 26(46):7287-7298. PubMed ID: 33362384 [TBL] [Abstract][Full Text] [Related]
22. Artificial Intelligence-The Rising Star in the Field of Gastroenterology and Hepatology. Stan-Ilie M; Sandru V; Constantinescu G; Plotogea OM; Rinja EM; Tincu IF; Jichitu A; Carasel AE; Butuc AC; Popa B Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832150 [TBL] [Abstract][Full Text] [Related]
23. Artificial intelligence: A review of current applications in hepatocellular carcinoma imaging. Pellat A; Barat M; Coriat R; Soyer P; Dohan A Diagn Interv Imaging; 2023 Jan; 104(1):24-36. PubMed ID: 36272931 [TBL] [Abstract][Full Text] [Related]
24. Artificial intelligence in intestinal polyp and colorectal cancer prediction. Sharma A; Kumar R; Yadav G; Garg P Cancer Lett; 2023 Jul; 565():216238. PubMed ID: 37211068 [TBL] [Abstract][Full Text] [Related]
25. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. Bo Z; Song J; He Q; Chen B; Chen Z; Xie X; Shu D; Chen K; Wang Y; Chen G Comput Biol Med; 2024 May; 173():108337. PubMed ID: 38547656 [TBL] [Abstract][Full Text] [Related]
26. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Li L; Li B; Zhang M Acta Radiol; 2020 Jun; 61(6):723-731. PubMed ID: 31594382 [TBL] [Abstract][Full Text] [Related]
27. Artificial intelligence in gastroenterology: A state-of-the-art review. Kröner PT; Engels MM; Glicksberg BS; Johnson KW; Mzaik O; van Hooft JE; Wallace MB; El-Serag HB; Krittanawong C World J Gastroenterol; 2021 Oct; 27(40):6794-6824. PubMed ID: 34790008 [TBL] [Abstract][Full Text] [Related]
28. Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases. Ahn JC; Connell A; Simonetto DA; Hughes C; Shah VH Hepatology; 2021 Jun; 73(6):2546-2563. PubMed ID: 33098140 [TBL] [Abstract][Full Text] [Related]
30. [Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma]. Jung EM; Uller W; Stroszczynski C; Clevert DA Radiologe; 2011 Jun; 51(6):462-8. PubMed ID: 21557022 [TBL] [Abstract][Full Text] [Related]
31. Artificial intelligence techniques in liver cancer. Wang L; Fatemi M; Alizad A Front Oncol; 2024; 14():1415859. PubMed ID: 39290245 [TBL] [Abstract][Full Text] [Related]
32. Current status of artificial intelligence analysis for endoscopic ultrasonography. Kuwahara T; Hara K; Mizuno N; Haba S; Okuno N; Koda H; Miyano A; Fumihara D Dig Endosc; 2021 Jan; 33(2):298-305. PubMed ID: 33098123 [TBL] [Abstract][Full Text] [Related]
33. Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review. Lai Q; Spoletini G; Mennini G; Laureiro ZL; Tsilimigras DI; Pawlik TM; Rossi M World J Gastroenterol; 2020 Nov; 26(42):6679-6688. PubMed ID: 33268955 [TBL] [Abstract][Full Text] [Related]
34. Artificial intelligence assists identifying malignant versus benign liver lesions using contrast-enhanced ultrasound. Hu HT; Wang W; Chen LD; Ruan SM; Chen SL; Li X; Lu MD; Xie XY; Kuang M J Gastroenterol Hepatol; 2021 Oct; 36(10):2875-2883. PubMed ID: 33880797 [TBL] [Abstract][Full Text] [Related]
35. Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: A review. Jiménez Pérez M; Grande RG World J Gastroenterol; 2020 Oct; 26(37):5617-5628. PubMed ID: 33088156 [TBL] [Abstract][Full Text] [Related]
36. Challenges involved in the application of artificial intelligence in gastroenterology: The race is on! Christou CD; Tsoulfas G World J Gastroenterol; 2023 Dec; 29(48):6168-6178. PubMed ID: 38186861 [TBL] [Abstract][Full Text] [Related]
37. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging. Peng J; Kang S; Ning Z; Deng H; Shen J; Xu Y; Zhang J; Zhao W; Li X; Gong W; Huang J; Liu L Eur Radiol; 2020 Jan; 30(1):413-424. PubMed ID: 31332558 [TBL] [Abstract][Full Text] [Related]
38. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases. Dou JP; Yu J; Han ZY; Liu FY; Cheng ZG; Liang P Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061 [TBL] [Abstract][Full Text] [Related]
39. Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma. Hsieh C; Laguna A; Ikeda I; Maxwell AWP; Chapiro J; Nadolski G; Jiao Z; Bai HX Radiology; 2023 Nov; 309(2):e222891. PubMed ID: 37934098 [TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts. Nishida N; Yamakawa M; Shiina T; Mekada Y; Nishida M; Sakamoto N; Nishimura T; Iijima H; Hirai T; Takahashi K; Sato M; Tateishi R; Ogawa M; Mori H; Kitano M; Toyoda H; Ogawa C; Kudo M; J Gastroenterol; 2022 Apr; 57(4):309-321. PubMed ID: 35220490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]